Reason for withdrawal from publication
This review is permanently wirhdrawn. A new review, of individual patient data, is in preparation. In the meantime, for more information on tacrine, readers might refer to Qizilbash N, Whitehead A, Higgins J, Wilcock G, Schneider L, Farlow M. Cholinesterase inhibition for Alzheimer disease: a meta‐analysis of the tacrine trials. Dementia Trialists' Collaboration. JAMA. 1998; 280: 20: 1777‐82
The editorial group responsible for this previously published document have withdrawn it from publication.
Keywords: Humans, Alzheimer Disease, Alzheimer Disease/drug therapy, Cholinesterase Inhibitors, Cholinesterase Inhibitors/therapeutic use, Nootropic Agents, Nootropic Agents/therapeutic use, Tacrine, Tacrine/therapeutic use
What's new
| Date | Event | Description |
|---|---|---|
| 7 November 2008 | Amended | Converted to new review format. |
History
Protocol first published: Issue 4, 1998 Review first published: Issue 4, 1998
| Date | Event | Description |
|---|---|---|
| 12 March 2001 | Amended | review withdrawn |
| 16 November 1998 | New citation required and conclusions have changed | Substantive amendment |
Sources of support
Internal sources
Hospital Cantoblanco, Madrid, Spain.
University of Oxford, UK.
External sources
Anglia & Oxford National Health Service Executive, UK.
UK Medical Research Council, UK.
Withdrawn from publication for reasons stated in the review